News & Updates
Filter by Specialty:
NCHT improves PFS in locally advanced prostate cancer
06 May 2024
byStephen Padilla
Neoadjuvant chemohormonal therapy (NCHT) plus radical prostatectomy (RP) confers significant biochemical progression-free survival (bPFS) benefits relative to neoadjuvant hormonal therapy (NHT) plus RP on patients with high-risk, locally advanced prostate cancer, reports a study.
NCHT improves PFS in locally advanced prostate cancer
06 May 2024MIRASOL PRO data boost mirvetuximab soravtansine potential in FRα-positive ovarian cancer
06 May 2024
byAudrey Abella
Patient-reported outcomes (PROs) from the phase III MIRASOL trial underpin the potential of the antibody drug conjugate mirvetuximab soravtansine (MIRV) to improve health-related quality of life (HRQoL) in women with folate receptor-alpha positive platinum-resistant ovarian cancer (FRα-positive PROC) as opposed to investigator’s choice of chemotherapy.